European Case Law Identifier: | ECLI:EP:BA:2012:T240210.20120510 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 10 May 2012 | ||||||||
Case number: | T 2402/10 | ||||||||
Application number: | 02009255.7 | ||||||||
IPC class: | C07C 405/00 A61K 31/557 A61P 27/02 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension | ||||||||
Applicant name: | Pfizer Health AB | ||||||||
Opponent name: | Breath Limited Apotex España SL ALAPIS S.A. |
||||||||
Board: | 3.3.10 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Amendments (allowable) - no added matter Novelty (yes) Inventive step (yes) - solution not obvious Double patenting (no) - not the same subject-matter |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t102402eu1.html
Date retrieved: 17 May 2021
23 references found.
Click X to load a reference inside the current page, click on the title to open in a new page.EPC Articles
Offical Journal of the EPO
XOJ EPO 2020, A104 - Interlocutory Decision of Technical Board of Appeal 3.3.01 dated 7 February 2019 - T 318/14